tradingkey.logo
tradingkey.logo

Codexis Inc

CDXS
1.703USD
+0.043+2.59%
取引時間 ET15分遅れの株価
153.75M時価総額
損失額直近12ヶ月PER

Codexis Inc

1.703
+0.043+2.59%

詳細情報 Codexis Inc 企業名

Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Codexis Incの企業情報

企業コードCDXS
会社名Codexis Inc
上場日Apr 22, 2010
最高経営責任者「CEO」Moore (Alison)
従業員数188
証券種類Ordinary Share
決算期末Apr 22
本社所在地200 Penobscot Dr
都市REDWOOD CITY
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号94063
電話番号16504218100
ウェブサイトhttps://www.codexis.com/
企業コードCDXS
上場日Apr 22, 2010
最高経営責任者「CEO」Moore (Alison)

Codexis Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
+26.74%
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
177.46K
+91.93%
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+10.73%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.05%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
132.05K
+45.00%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
+46.54%
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
+57.58%
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
87.42K
-1.59%
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
+92.83%
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
70.64K
-8.12%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
+26.74%
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
177.46K
+91.93%
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+10.73%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.05%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
132.05K
+45.00%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
+46.54%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
APAC
6.58M
42.93%
America
6.35M
41.44%
EMEA
2.40M
15.63%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
Opaleye Management Inc.
9.95%
BlackRock Institutional Trust Company, N.A.
6.50%
The Vanguard Group, Inc.
5.17%
abrdn Inc.
4.53%
Millennium Management LLC
4.50%
他の
69.34%
株主統計
株主統計
比率
Opaleye Management Inc.
9.95%
BlackRock Institutional Trust Company, N.A.
6.50%
The Vanguard Group, Inc.
5.17%
abrdn Inc.
4.53%
Millennium Management LLC
4.50%
他の
69.34%
種類
株主統計
比率
Investment Advisor
27.10%
Hedge Fund
21.96%
Investment Advisor/Hedge Fund
19.88%
Individual Investor
2.88%
Research Firm
1.22%
Pension Fund
0.20%
Bank and Trust
0.18%
Insurance Company
0.03%
Venture Capital
0.02%
他の
26.52%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
259
63.79M
84.44%
-3.19M
2025Q3
270
67.24M
85.39%
-6.33M
2025Q2
272
73.50M
96.12%
+3.66M
2025Q1
304
67.35M
93.04%
-9.72M
2024Q4
323
66.35M
93.32%
+1.38M
2024Q3
331
65.10M
96.64%
+10.35M
2024Q2
345
54.66M
101.93%
-1.25M
2024Q1
358
56.38M
110.38%
-21.50M
2023Q4
374
58.04M
110.76%
+374.07K
2023Q3
379
57.61M
110.71%
-5.54M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Opaleye Management Inc.
12.61M
13.97%
+10.00K
+0.08%
Jul 30, 2025
BlackRock Institutional Trust Company, N.A.
5.85M
6.48%
-376.85K
-6.05%
Jun 30, 2025
The Vanguard Group, Inc.
4.59M
5.08%
-135.73K
-2.87%
Jun 30, 2025
abrdn Inc.
4.20M
4.65%
+3.59M
+592.89%
Jun 30, 2025
Nantahala Capital Management, LLC
4.03M
4.47%
+1.20M
+42.39%
Jun 30, 2025
Telemark Asset Management, LLC
4.00M
4.43%
+1.00M
+33.33%
Jun 30, 2025
Columbia Threadneedle Investments (US)
2.55M
2.83%
+16.10K
+0.64%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.98M
2.19%
+52.59K
+2.73%
Jun 30, 2025
Pier Capital, LLC
1.92M
2.12%
+245.96K
+14.73%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco NASDAQ Future Gen 200 ETF
0.47%
iShares Micro-Cap ETF
0.04%
Invesco Nasdaq Biotechnology ETF
0.02%
Fidelity Enhanced Small Cap ETF
0.02%
iShares Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
Global X Russell 2000 ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
詳細を見る
Invesco NASDAQ Future Gen 200 ETF
比率0.47%
iShares Micro-Cap ETF
比率0.04%
Invesco Nasdaq Biotechnology ETF
比率0.02%
Fidelity Enhanced Small Cap ETF
比率0.02%
iShares Biotechnology ETF
比率0.02%
ProShares Ultra Nasdaq Biotechnology
比率0.02%
Global X Russell 2000 ETF
比率0.01%
Invesco RAFI US 1500 Small-Mid ETF
比率0.01%
Proshares Ultra Russell 2000
比率0.01%
iShares Russell 2000 Growth ETF
比率0.01%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Codexis Incの上位5名の株主は誰ですか?

Codexis Incの上位5名の株主は以下のとおりです。
Opaleye Management Inc.は12.61M株を保有しており、これは全体の13.97%に相当します。
BlackRock Institutional Trust Company, N.A.は5.85M株を保有しており、これは全体の6.48%に相当します。
The Vanguard Group, Inc.は4.59M株を保有しており、これは全体の5.08%に相当します。
abrdn Inc.は4.20M株を保有しており、これは全体の4.65%に相当します。
Nantahala Capital Management, LLCは4.03M株を保有しており、これは全体の4.47%に相当します。

Codexis Incの株主タイプ上位3種は何ですか?

Codexis Incの株主タイプ上位3種は、
Opaleye Management Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

Codexis Inc(CDXS)の株式を保有している機関の数はいくつですか?

2025Q4時点で、Codexis Incの株式を保有している機関は259社あり、保有株式の総市場価値は約63.79Mで、全体の84.44%を占めています。2025Q3と比較して、機関の持ち株は-0.95%増加しています。

Codexis Incの最大の収益源は何ですか?

FY2025Q2において、--部門がCodexis Incにとって最大の収益を生み出しており、その金額は--で、全収益の--%を占めています。
KeyAI